Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
11.23
-0.19 (-1.66%)
At close: Sep 12, 2025, 4:00 PM EDT
11.46
+0.23 (2.05%)
After-hours: Sep 12, 2025, 4:25 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $153.61 million as of September 12, 2025. Its market cap has decreased by -20.07% in one year.
Market Cap
153.61M
Enterprise Value
153.35M
1-Year Change
-20.07%
Ranking
Category
Stock Price
$11.23
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $153.61M, an increase of 123.64%. That is a compound annual growth rate of 17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 155.66M | 5.45% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
| Sep 25, 2020 | 68.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.85B |
| Johnson & Johnson | 426.18B |
| AbbVie | 371.72B |
| UnitedHealth Group | 315.10B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 229.65B |